Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Catapult Ventures Group is a venture capital firm founded in 2006 and based in Leicester, UK. The firm operates as an independent fund manager, focusing on creating value through long-term relationships with portfolio companies and investors. Catapult Ventures manages multiple funds totaling approximately £130 million, targeting growth opportunities primarily in the UK. The firm has established a reputation for its expertise in various sectors, including healthcare, pharmaceuticals, luxury consumer brands, manufacturing, and software.
Over the years, Catapult Ventures has evolved to specialize in seed and early-stage investments, particularly in the life sciences sector. The firm has achieved notable milestones, including successful exits from several portfolio companies. Their approach emphasizes collaboration and innovation, which has allowed them to build a strong track record in supporting ambitious entrepreneurs and management teams.
Currently, Catapult Ventures Group operates from its headquarters in Leicester, UK, and has a diverse LP base that includes institutional investors and high-net-worth individuals. The firm is recognized for its active involvement in the growth and strategic development of its portfolio companies, ensuring that they are well-positioned for success in their respective markets.
Catapult Ventures Group focuses on seed and early-stage investments, primarily in the life sciences sector, which includes healthcare, biotechnology, and digital health technologies. The firm seeks to identify and support innovative companies that have the potential to make a significant impact in their fields. Their investment strategy emphasizes long-term relationships with founders and management teams, allowing them to provide tailored support and guidance throughout the growth process.
The firm typically invests in companies that are at the forefront of technological advancements in healthcare and life sciences. Catapult Ventures aims to create value through active board participation, leveraging the team's extensive industry expertise and networks. This approach not only helps portfolio companies navigate challenges but also fosters collaboration and innovation within the sector.
Investment checks generally range from seed funding to early-stage capital, aligning with the firm's commitment to supporting businesses that are poised for growth. Catapult Ventures is particularly interested in companies that demonstrate a clear vision and the potential for scalability, making them attractive candidates for investment.
Catapult Ventures Group has a diverse portfolio of companies, particularly in the healthcare and life sciences sectors. Notable portfolio companies include:
These companies represent a mix of successful exits and ongoing investments, showcasing Catapult Ventures' ability to identify high-potential startups. The firm has consistently focused on businesses that are innovating within their respective fields, particularly in digital health and biotechnology.
Duncan Cameron: Managing Partner with extensive experience in venture capital and a focus on healthcare investments.
Professor Rob Carroll: Partner with a background in life sciences and a strong academic foundation, contributing to the firm's expertise in biotechnology.
Dr. Tony Flinn: Partner specializing in digital health technologies, with a track record of successful investments in the sector.
Dr. Gareth King: Partner with a focus on pharmaceuticals and healthcare innovation, bringing valuable insights to the investment process.
Kevin D'Silva: Partner with experience in luxury consumer brands and manufacturing, adding diversity to the firm's investment strategy.
Laurence Vaughan: Partner with a strong background in software investments, enhancing the firm's technological focus.
Dr. David Whitcombe: Partner with expertise in diagnostics and medical devices, contributing to the firm's life sciences specialization.
Nick Wright: Partner with a focus on operational support for portfolio companies, ensuring they have the resources needed for growth.
Hamish Graham: Advisor with extensive experience in venture capital and a network of industry contacts that benefit portfolio companies.
To pitch to Catapult Ventures Group, founders should use the preferred channel of their website or email. It is important to include a comprehensive pitch deck that outlines the business model, market analysis, and financial projections. The firm typically responds within a reasonable timeframe, but founders are encouraged to follow up if they do not receive a timely response. Warm introductions can enhance the chances of securing a meeting.
In recent months, Catapult Ventures Group has made headlines with several notable investments and activities. The firm announced an investment in MyHelp, a digital health startup, showcasing its commitment to supporting innovative solutions in healthcare.
Additionally, Catapult Ventures has achieved significant returns from its portfolio companies, with notable exits including Accutronics, Lumora, and Oxford Cryosystems. These successful exits highlight the firm's ability to identify and nurture high-potential startups.
Catapult Ventures Group continues to be recognized in the venture capital community, ranking among the top biotech startup investors in the UK, as reported by Shizune in January 2026.
What are Catapult Ventures Group's investment criteria?
Catapult Ventures Group primarily invests in seed and early-stage businesses within the life sciences sector, including healthcare, biotechnology, and digital health. The firm looks for innovative companies with strong growth potential and a clear vision for scalability.
How can I apply or pitch to Catapult Ventures Group?
Founders can pitch their ideas through the firm's website at catapult-ventures.com or by emailing their pitch deck to mail@catapult-ventures.com. It is advisable to include a clear business plan and financial projections in the pitch.
What makes Catapult Ventures Group different from other venture capital firms?
Catapult Ventures Group emphasizes long-term relationships with portfolio companies and active board participation. This approach allows them to provide tailored support and leverage their extensive industry expertise to help companies grow.
What is the geographic scope of Catapult Ventures Group's investments?
The firm primarily targets investments in the United States, focusing on innovative startups in the healthcare and life sciences sectors.
What is the typical check size for investments?
Catapult Ventures Group typically invests in seed and early-stage rounds, with check sizes varying based on the specific needs of the startup and the stage of development.
What kind of post-investment involvement can portfolio companies expect?
Catapult Ventures Group actively participates in the boards of its portfolio companies, providing strategic guidance and support to help them navigate challenges and capitalize on growth opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.